WO2000066055A1 - Bandage - Google Patents
Bandage Download PDFInfo
- Publication number
- WO2000066055A1 WO2000066055A1 PCT/RU2000/000160 RU0000160W WO0066055A1 WO 2000066055 A1 WO2000066055 A1 WO 2000066055A1 RU 0000160 W RU0000160 W RU 0000160W WO 0066055 A1 WO0066055 A1 WO 0066055A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- film
- retractable
- medium
- fact
- drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims abstract description 7
- 229940088623 biologically active substance Drugs 0.000 claims abstract 3
- 210000002950 fibroblast Anatomy 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 10
- 229940035674 anesthetics Drugs 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 239000003193 general anesthetic agent Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 230000002441 reversible effect Effects 0.000 claims 2
- 241001124076 Aphididae Species 0.000 claims 1
- 208000011623 Obstructive Lung disease Diseases 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940088679 drug related substance Drugs 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- -1 polyethylene Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
- 239000007789 gas Substances 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 210000002510 keratinocyte Anatomy 0.000 abstract description 2
- 230000000149 penetrating effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000000047 product Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940053973 novocaine Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00182—Wound bandages with transparent part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00246—Wound bandages in a special way pervious to air or vapours
- A61F2013/00251—Wound bandages in a special way pervious to air or vapours with macroscopic openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00846—Plasters with transparent or translucent part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00859—Plasters pervious to air or vapours with macroscopic openings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- a medical aid for the treatment of a wound, containing a layer of activated carbon, carried out on the basis of viscose 5th.
- the knitting pattern has a gray color with a fabric density of 165-175 threads / 10 cm for basic threads, and 105-115 threads / 10 cm for fasteners, and it has a gap of 10-150 cm / h.
- filaments with a large cross-section the maximum size is not more than 14 ⁇ m, and the minimum is not less than 7 ⁇ m (see 0 patent ⁇ ⁇ ° 2000762 ⁇ ⁇ 61 ⁇ 10/54.
- the well-known medical connection ensures that there is no return of the ex-court and any microorganisms that are not affected, but it does not affect the visibility 5
- a well-known synthetic strap that contains absorbent liquid and is suitable for non-containment with locking elements.
- the restraining package is made of an elastic tape (see the original certificate of the USSR ⁇ 180 ⁇ ⁇ 1803083 ⁇ p ⁇ 61 ⁇ 13/00, published March 23, 93). 0
- a well-known connection suppresses a harmful microcircuit, ensures the return of an emergency exudation, it has a complex operation and does not 2. Provides visual control over the location of the wound.
- a medical aid made in the form of a moistened meal from a foam is known (see the original certificate of the USSR, dated 1822796, publication date ⁇ 61 February 23/03, 03/03/00. 5
- a well-known binding has a limited area of application, since it is used only in the treatment of burns and rinse in an acidic bar magnets.
- a custom form of retractable equipment is a rinse device.
- various types of chemicals have been developed, which are distinguished by the chemical composition of the base, which is added to the medicinal products.
- s ⁇ de ⁇ - z haschaya ⁇ lime ⁇ nuyu ⁇ len ⁇ u on ⁇ sn ⁇ ve ⁇ li ⁇ le ⁇ in ⁇ v ⁇ lschin ⁇ y ⁇ 20 d ⁇ m ⁇ m 150 associated with s ⁇ btsi ⁇ nn ⁇ y ⁇ d ⁇ m on ⁇ ivi ⁇ m in ⁇ lsche ⁇ len- ⁇ i ⁇ -vinil ⁇ i ⁇ lid ⁇ n ⁇ m (see.
- the medical treatment has an anti-theft action, 3 in the process of processing the film to receive the bactericidal properties of it, it is discarded in the color and, thereby, the process is lost.
- the well-known quick-change- 5 sharp material does not interfere with the gas exchange of the entire environment, which is not necessary for the environment.
- the film has a low adhesion to wraparound surfaces and requires an additional fixation with a pad or bandage.
- the film may have been treated with an antiseptic (for example, chlorinated acid, iodine or its analogs, katapol and other well-known antisystems).
- the film may be coated with anesthetics (for example, novocaine, anilokain and other well-known anesthetics).
- the film can also be treated with drugs that stimulate 0 pharmaceutical processes in ryan (for example, industrial oil,
- film it may be inferred at least one layer of the antiseptic (for example, chlorine hydroxadine, iodine or its analogs, bypassed and not known).
- Film may be printed on 5 less one-layer anesthetics (for example, novokain, anilokain and other well-known anesthetics).
- anesthetics for example, novokain, anilokain and other well-known anesthetics.
- a lower measure of a single drug stimulating the process in an oil (for example, a by-product of oil is consumed)
- thermophosphate carboxymethyl cellulose, polyimide, and potassium oxide.
- the film thickness can be between 3 and 100 microns. Disappearing holes in the film may be made cylindrical, cynical or narrowed in the central part. The last two types of acces- sions are predominantly used for the treatment of films of medicinal products and / or biological active substances. Due to the inaccuracies of the video, the friends of the friend and the friend can be parallel to the film.
- the film may also be equipped with an additional design (with straight fittings with a diameter of 1 - 3 mm, located at a distance of 5 - 10 mm of the arc of the other).
- the film has a thickness of less than 3 ⁇ m, the diameter of the holes is greater than 3.0 ⁇ m and the density of the holes is greater than 10 9 1 / cm 2 , that is, its mechanical size is inaccessible. With a film thickness of more than 100 ⁇ m, the diameter is less than
- the claimed first-hand medium reliably restrains on the old-fashioned charge.
- Damaged tapes of live cassettes allow the use of the claimed device for the purpose of restoring non-compliant P ⁇ i ⁇ a ⁇ e ⁇ evyaz ⁇ chn ⁇ g ⁇ s ⁇ eds ⁇ va an ⁇ ise ⁇ i ⁇ ami or applying a i ⁇ sl ⁇ ya s ⁇ s ⁇ bs ⁇ vue ⁇ ⁇ davleniyu ⁇ a ⁇ genn ⁇ y mi ⁇ l ⁇ y and ⁇ i ⁇ a anes ⁇ e ⁇ i ⁇ ami i ⁇ or applying a sl ⁇ ya ⁇ zv ⁇ lyae ⁇ ⁇ asshi ⁇ i ⁇ ⁇ blas ⁇ ⁇ imeneniya ⁇ e ⁇ evyaz ⁇ chn ⁇ g ⁇ s ⁇ eds ⁇ va. 5 Filling of food in the film with over-sized oils, quick-cooking, pine and other convenient products, as well as
- FIG. 1 indicated non-mating disassociation with cylindrical discharges at a specific cut; on ⁇ ig. 2 Incidentally, due to direct contact with other parties; on ⁇ ig. 3 is shown a transverse cut through a non-mating closure with a stripe - 5 mi narrowed in the central part; on ⁇ ig. 4 shown non-tethering equipment, equipped with one of the live parts of the live cage.
- the density of holes 2 ⁇ is (10 3 - 10 9 ) 1 / cm 2 .
- Part 2 may be cylindrical (Fig. 1), finite (Fig. 2) or narrowed in the central part (Fig. 3). If you have 2 defects, you can be parallel to each other (Fig. 3) and may be located at 3 different angles of 1 (different angles).
- a variant of a retractable medication on one of the lenses of 3 films 1 is made up of 4 live animals (for example, an injury rate of 1).
- This option of a non-malfunctioning device is used in the event of the restoration of injuries of the corresponding patient.
- films are filled with drugs and / or biological active substances.
- a retractable medication is applied to a film at a lower cost of a single drug and / or biologic product.
- the fourth and fourth version of a retractable medication is used as an antiseptic and medical treatment.
- the claimed retractable product is manufactured in the following manner.
- a large film with a thickness of 3-100 ⁇ m, for example, is electrically impaired, emits accelerated heavy ions, for example, carbon, acid, for example,
- the energy and energy are selected by the calculated method, depending on the energy of the particles, and the resulting film is lost.
- the specified rotational mode (cylindrical, cinical, or narrowed in the main part) is obtained by choosing the corresponding 5 form and energy used for bombing. Further, the film processed by the corresponding ions is irradiated with ultraviolet radiation, and then the chemical treatment is avoided, which leads to a non-refraction. It follows that there is an option for adjusting the settings and also for operating modes of the film processing machine, i.e. Sensitizing ultraviolet irradiation and chemical control modes. Thus, for production of holes with a shape that is close to cylindrical, the solution is manufactured at a high temperature and diluted clicks. Compressor costs at a rate of 5 losses result in the formation of narrowed constrictions in the central part.
- Cultivation may be subject to a number of known variations.
- a direct medium ⁇ consisting of a mixture of medium ⁇ and ⁇ 12 at a ratio of 3: 1, with the addition of a 10% emulsion, free of charge 5 m ⁇ g / ml gid ⁇ iz ⁇ na gemisu ⁇ tsinaga ( ⁇ dg ⁇ a) adenina- 51 810 "4 ⁇ , ⁇ ans ⁇ e ⁇ ina - 51 m ⁇ g ml li ⁇ i ⁇ nina - 2 10" 10 ⁇ , ⁇ le ⁇ - n ⁇ g ⁇ ⁇ sina - 10 "10 ⁇ , e ⁇ ide ⁇ maln ⁇ g ⁇ ⁇ a ⁇ a ⁇ s ⁇ a (E ⁇ ) - 10ng / ml.
- cultivation of the carcasses may result in the card being in the presence of a feeder condition, and without it is inactive.
- P ⁇ i is ⁇ l- z ⁇ vanii for ⁇ ul ⁇ ivi ⁇ vaniya on ⁇ len ⁇ e ⁇ ib ⁇ blas ⁇ v, vydelenny ⁇ of ⁇ zhi ⁇ b ⁇ zhzhenny ⁇ b ⁇ lny ⁇ , ne ⁇ b ⁇ dim ⁇ ⁇ v ⁇ di ⁇ in case ⁇ azhd ⁇ m m ⁇ ⁇ l ⁇ giches ⁇ ie issled ⁇ vaniya and vi ⁇ us ⁇ l ⁇ giches ⁇ ie ⁇ es ⁇ y for ⁇ ed ⁇ - v ⁇ ascheniya za ⁇ azheniya ⁇ etsi ⁇ ien ⁇ a ⁇ ansmissivnymi zab ⁇ levaniyami.
- Diploid cells taken from 6 to 20 gates, are distinguished by the stable stability of the biological and biological properties and the good health of 20 ⁇ ib ⁇ blas ⁇ y ⁇ ul ⁇ ivi ⁇ uyu ⁇ on ⁇ ve ⁇ n ⁇ s ⁇ i ⁇ len ⁇ i, na ⁇ ime ⁇ ⁇ lie ⁇ i- 0 len ⁇ e ⁇ e ⁇ ala ⁇ a, ⁇ luchenn ⁇ y ⁇ isannym s ⁇ s ⁇ b ⁇ m above, d ⁇ ⁇ mi ⁇ - Bani m ⁇ n ⁇ sl ⁇ ya ⁇ ib ⁇ blas ⁇ v, ⁇ sle cheg ⁇ ⁇ e ⁇ evyaz ⁇ chn ⁇ e s ⁇ eds ⁇ v ⁇ g ⁇ - ⁇ v ⁇ for is ⁇ lz ⁇ vaniya.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention, qui se rapporte au domaine de la médecine, concerne un bandage et peut être utilisée dans un grand nombre d'applications. Ce bandage laisse passer uniformément les gaz qui sont nécessaires au déroulement efficace des processus réparateurs, et empêche simultanément la pénétration de micro-organismes dans la blessure. Ce bandage comprend un film biocompatible (1) fait d'un polymère transparent et comportant des ouvertures traversantes (2). Ce bandage se caractérise en ce que les ouvertures (2) ont un diamètre D = (0,01 - 3,0) νm et en ce que la densité des ouvertures est de N = (10?3 - 109) 1/cm2¿. Dans un deuxième mode de réalisation, ce bandage comprend en outre, sur une des surfaces (3) du film (1), une couche de cellules vivantes (4) telles que des kératinocytes ou des fibroblastes. Dans un troisième mode de réalisation, ce bandage se distingue de celui du premier mode de réalisation en ce que le film (1) est imprégné d'une préparation médicamenteuse et/ou d'une substance bioactive. Dans un quatrième mode de réalisation, le bandage se distingue de celui du troisième mode de réalisation en ce que la préparation médicamenteuse et/ou la substance bioactive sont appliquées sur le film (1) sous forme d'au moins une couche. Les ouvertures traversantes (2) pratiquées dans le film (1) peuvent avoir des formes diverses.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99109728 | 1999-04-30 | ||
RU99109728 | 1999-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000066055A1 true WO2000066055A1 (fr) | 2000-11-09 |
Family
ID=20219613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2000/000160 WO2000066055A1 (fr) | 1999-04-30 | 2000-04-19 | Bandage |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2000066055A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0265906A2 (fr) * | 1986-10-31 | 1988-05-04 | Nippon Zeon Co., Ltd. | Pansement |
DE3723404A1 (de) * | 1987-07-15 | 1989-01-26 | Aoe Plastic Gmbh | Fluessigkeitsdurchlaessige folie, insbesondere als deckfolie fuer saugstoff, sowie verfahren zu deren herstellung |
US5650164A (en) * | 1990-06-01 | 1997-07-22 | Fidia S.P.A. | Process for preparing artificial skin with biocompatible perforated membranes |
RU2106154C1 (ru) * | 1996-08-16 | 1998-03-10 | Василий Александрович Мензул | Перевязочный материал |
-
2000
- 2000-04-19 WO PCT/RU2000/000160 patent/WO2000066055A1/fr not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0265906A2 (fr) * | 1986-10-31 | 1988-05-04 | Nippon Zeon Co., Ltd. | Pansement |
DE3723404A1 (de) * | 1987-07-15 | 1989-01-26 | Aoe Plastic Gmbh | Fluessigkeitsdurchlaessige folie, insbesondere als deckfolie fuer saugstoff, sowie verfahren zu deren herstellung |
US5650164A (en) * | 1990-06-01 | 1997-07-22 | Fidia S.P.A. | Process for preparing artificial skin with biocompatible perforated membranes |
RU2106154C1 (ru) * | 1996-08-16 | 1998-03-10 | Василий Александрович Мензул | Перевязочный материал |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012326206B2 (en) | Method of forming hemostatic products | |
US9555157B2 (en) | Method of inducing hemostasis in a wound | |
US11109955B2 (en) | Dermal layer for grafting having improved graft survival rate and method for producing same | |
US20160193381A1 (en) | Hemostatic products | |
Andleeb et al. | Developing affordable and accessible pro‐angiogenic wound dressings; incorporation of 2 deoxy D‐ribose (2dDR) into cotton fibres and wax‐coated cotton fibres | |
US20180361012A1 (en) | Hemostatic products | |
WO2000066055A1 (fr) | Bandage | |
US20180344891A1 (en) | Electrospun dextran fibers and devices formed therefrom | |
AU2012326201B2 (en) | Method of forming dextran and thrombin sheets | |
US20160038627A1 (en) | Method of causing delayed hemostasis | |
AU2016351557A1 (en) | A method of sealing a durotomy | |
DE102009042791A1 (de) | Halbfeste Zubereitungen biologischer Arzneimittel | |
John Cedrick et al. | A Meta-Analysis on the Effectivity and Efficiency of Bacterial Cellulose in Wound Healing Compared to Conventional Methods of Wound Management in Adult Patients with Venous Ulcers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WA | Withdrawal of international application |